Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas

Avaniyapuram Kannan Murugan1, Nguyen Thi Hong, Yasuhisa Fukui

  • 1Department of Molecular Cellular Oncology and Microbiology, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo 113-8549, Japan.

Insights

Mutations in PIK3CA, a key gene in head and neck cancers, enhance cell growth and invasion. This study reveals PIK3CA mutations in Indian HNSCC, offering potential therapeutic targets.

Area of Science:

  • Molecular Oncology
  • Cancer Genomics
  • Cell Signaling Pathways

Background:

  • Phosphatidylinositol 3-kinases (PI3Ks) regulate critical cellular functions.
  • The catalytic subunit PIK3CA is frequently mutated in various cancers.
  • PIK3CA mutations in head and neck squamous cell carcinomas (HNSCC) and their functional impact remain underexplored, especially across diverse ethnicities.

Purpose of the Study:

  • To investigate the prevalence and functional consequences of PIK3CA mutations in HNSCC.
  • To analyze the co-occurrence of PIK3CA mutations with other key signaling genes (PTEN, RAS, EGFR).
  • To assess the oncogenic potential of HNSCC-associated PIK3CA mutants.

Main Methods:

  • Exon sequencing of PIK3CA in 54 HNSCC samples (cell lines, Indian, and Vietnamese tumors).
  • Analysis of PI3K signaling pathway genes (PTEN, RAS, EGFR).
  • Functional assays evaluating PI3 kinase activity, colony formation, morphology, migration, and invasion.

Main Results:

  • PIK3CA mutations were identified in 29.4% of cell lines and 10.5% of Indian tumors, but not in Vietnamese tumors.
  • PIK3CA and PTEN mutations were mutually exclusive; PIK3CA mutations coexisted with H-RAS mutations and were mutually exclusive to EGFR amplification.
  • All identified PIK3CA mutants exhibited increased PI3 kinase activity, enhanced growth factor-independent proliferation, altered morphology, and increased migration/invasion.

Conclusions:

  • PIK3CA mutations are oncogenic drivers in HNSCC, contributing to cancer development.
  • This study provides the first functional analysis of PIK3CA mutants in HNSCC and reports mutations in Indian and Vietnamese populations.
  • Targeting PIK3CA mutations represents a promising therapeutic strategy for HNSCC.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...